Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ASCENDIS PHARMA A/S

(ASND)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ASCENDIS PHARMA A/S
01/13Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Gr..
AQ
01/10Ascendis Pharma A/S Provides Update on Vision 3x3 Strategic Roadmap at 40th Annual J.P...
AQ
01/04Ascendis Pharma A/S to Participate in 40th Annual J.P. Morgan Healthcare Conference
GL
2021Ascendis Pharma A/S Virtual R&D Program Update Highlights Continued Development Across ..
AQ
2021Ascendis Pharma A/S to Host Virtual R&D Program Update on December 14
GL
2021Ascendis Pharma A/S Announces Top-Line Results from Week 84 of Its Phase 2 PaTH Forwar..
GL
2021Ascendis Pharma A/S to Participate in the Evercore ISI 4th Annual HealthCONx Conference
AQ
2021Ascendis Pharma A/S - Share Repurchase Program Update
AQ
2021Ascendis Pharma A/S Receives Positive CHMP Opinion for TransCon™ hGH for Patients..
GL
2021Ascendis Pharma A/S Reports Third Quarter 2021 Financial Results - Form 6-K
PU
2021ASCENDIS PHARMA A/S INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEME..
PU
2021Ascendis Pharma A/S Reports Third Quarter 2021 Financial Results
AQ
2021Ascendis Pharma A/S Presents New Non-Clinical Data for TransCon™ TLR7/8 Agonist O..
AQ
2021Ascendis Pharma A/S - Share Repurchase Program Update
AQ
2021Ascendis Pharma A/S Announces Third Quarter 2021 Financial Results and Business Update ..
AQ
2021ASCENDIS PHARMA A/S : Notice to convene Extraordinary General Meeting - Form 6-K
PU
2021ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE - Form 6-K
PU
2021ASCENDIS PHARMA A/S : Announces U.S. Commercial Launch of SKYTROFA® (Lonapegsomatropin-tcg..
AQ
2021ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
PU
2021ASCENDIS PHARMA A/S : A/S Announces Presentations for TransCon™ PTH and TransCon&tra..
GL
2021ASCENDIS PHARMA A/S : Announces Share Repurchase Program
AQ
2021ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
PU
2021Ascendis Pharma A/S Announces Mean Bone Mineral Density (BMD) Data from Phase 2 PaTH Fo..
GL
2021ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
PU
2021Ascendis Pharma A/S Announces Upcoming Investor Presentations
GL
2021Ascendis Pharma A/S Submits Investigational New Drug Application to Initiate TransCon&t..
GL
2021Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
GL
2021Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
GL
2021ASCENDIS PHARMA A/S : Unaudited Condensed Consolidated Interim Statements of Profit or Los..
PU
2021ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
PU
2021ASCENDIS PHARMA A/S : Reports Second Quarter 2021 Financial Results (Form 6-K)
PU
2021ASCENDIS PHARMA A/S : Q2 Earnings and Skytrofa® FDA Approval Call
PU
2021Ascendis Pharma A/S Reports Second Quarter 2021 Financial Results
GL
2021Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (..
GL
2021Ascendis Pharma A/S Announces Second Quarter 2021 Financial Results and Business Update..
GL
2021ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
PU
2021ASCENDIS PHARMA A/S : Announces Upcoming Investor Presentations in August
AQ
2021ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
PU
2021ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
PU
2021ASCENDIS PHARMA A/S : Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial of..
AQ
2021ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
PU
2021Ascendis Pharma A/S Announces Extension of U.S. Food and Drug Administration Review Per..
GL
2021ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
PU
2021ASCENDIS PHARMA A/S : The first hormone replacement therapy for hypoparathyroidism in Chin..
PR
2021ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
PU
2021ASCENDIS PHARMA A/S INVITES THE PUBL : Living with Hypoparathyroidism” in Support of..
GL
2021ASCENDIS PHARMA A/S : INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMEN..
PU
2021Ascendis Pharma A/S Reports First Quarter 2021 Financial Results
GL
2021Ascendis Pharma A/S Announces First Quarter 2021 Financial Results and Business Update ..
GL
2021Ascendis Pharma A/S Announces Expansion of Global Clinical Reach for TransCon™ PT..
GL
2021ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
PU
2021ASCENDIS PHARMA A/S : TransCon PTH PaTH Forward Trial 58-Week OLE Clinical Update Presenta..
PU
2021Ascendis Pharma A/S Announces Preliminary 58-Week Results from Open-Label Extension of ..
GL
2021Ascendis Pharma A/S Announces Presentations for TransCon™ PTH at Upcoming Medical..
GL
2021Ascendis Pharma A/S Announces Participation at the BofA Securities 2021 Virtual Health ..
GL
2021ASCENDIS PHARMA A/S : Election of Board Members 6. Election of State-authorized Public Aud..
PU
2021Ascendis Pharma A/S Announces Presentations for TransCon™ hGH at Upcoming Medical..
GL
2021Ascendis Pharma A/S Announces Participation at the J.P. Morgan 10th Annual Napa Valley ..
GL
2021Ascendis Pharma A/S Presents 6-Month Open-Label Extension Data from Phase 2 PaTH Forwar..
GL
2021Ascendis Pharma A/S Announces Participation at Oppenheimer 31st Annual Healthcare Confe..
GL
2021Ascendis Pharma A/S Reports Full Year 2020 Financial Results
GL
2021Ascendis Pharma A/S Announces Seven Presentations at ENDO 2021, Demonstrating Commitmen..
GL
2021Ascendis Pharma A/S Announces Full Year 2020 Financial Results and Business Update Conf..
GL
2021Ascendis Pharma A/S Announces New “Outgrow GHD” Educational Resource to Sup..
GL
2021Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcar..
GL
2021ASCENDIS PHARMA A/S : 39th Annual J.P. Morgan Healthcare Conference Presentation
PU
2021Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Co..
GL
2021Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals
GL
2021Ascendis Pharma A/S Announces Participation in 39th Annual J.P. Morgan Healthcare Confe..
GL
2020Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiat..
GL
2020Ascendis Pharma A/S Announces Planned Board Transition
GL
2020ASCENDIS PHARMA A/S : Announces Participation at the Evercore ISI 3rd Annual HealthCONx Vi..
AQ
2020Ascendis Pharma A/S Announces Participation at the Evercore ISI 3rd Annual HealthCONx V..
GL
2020ASCENDIS PHARMA A/S : 2020 Oncology R&D Day Presentation
PU
2020ASCENDIS PHARMA A/S : to Host Virtual Oncology R&D Day on Friday, November 20
AQ
1  2  3  4Next
Upcoming event on ASCENDIS PHARMA A/S